Data availability
No datasets were generated or analysed during the current study.
References
Nichol KA, Adam HJ, Golding GR, Lagacé-Wiens PRS, Karlowsky JA, Hoban DJ, Zhanel GG. Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD. Characterization of MRSA in Canada from 2007 to 2016. J Antimicrob Chemother. 2019;74(Suppl 4):iv55–63.
Park SY, Son JS, Oh IH, Choi JM, Lee MS. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores. Infection. 2011;39(2):141–7.
Fukushima S, Hagiya H, Kuninaga N, Haruki Y, Yamada H, Iwamoto Y, Yoshida M, Sato K, Hanayama Y, Tanaka S, Miyoshi T, Otsuka Y, Ueda K, Otsuka F. Adherence to and clinical utility of quality indicators for Staphylococcus aureus bacteremia: a retrospective, multicenter study. Infection. 2024;52(4):1527–38.
Adeiza SS, Aminul I. Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia. Infez Med. 2024;32(2):131–7.
Popovich KJ, Aureden K, Ham DC, Harris AD, Hessels AJ, Huang SS, Maragakis LL, Milstone AM, Moody J, Yokoe D, Calfee DP. SHEA/IDSA/APIC Practice recommendation: strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(7):1039–67.
Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A, Hagel S, Pletz MW. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25(7):818–27.
Ju G, Zhang Y, Ye C, Liu Q, Sun H, Zhang Z, Huang X, Jiang Y, Huang Q. Comparative effectiveness and safety of six antibiotics in treating MRSA infections: a network meta-analysis. Int J Infect Dis. 2024;146:107109.
Acknowledgements
The authors thank the staff of the participating hospitals for their assistance.
Funding
This study did not receive any funding.
Author information
Authors and Affiliations
Contributions
H.H. conceived the study; S.F., N.K., Y.H. (Haruki), H.Y., Y.I., M.Y., K.S., Y.H. (Hanayama), S.T., T.M., Y.O., and K.U. performed the data extraction; S.F. drafted the manuscript and performed the statistical analyses; H.H. revised the manuscript; and H.H. and F.O. supervised the study. All authors interpreted the results and approved the submission of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained from the Institutional Review Board of Okayama University Hospital (No. 2302-027).
Consent for publication
The requirement for informed consent was waived because this was a retrospective analysis of routinely collected anonymous data.
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Fukushima, S., Hagiya, H., Kuninaga, N. et al. Threat of MRSA bacteremia still matters: a propensity score matching analysis. Infection (2024). https://doi.org/10.1007/s15010-024-02382-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-024-02382-y